Kamada raises $51.6 million in Nasdaq IPO
At $9.25, the issue price for the Israeli pharmaceutical developer was 16.6% below the share's closing price in Tel Aviv the previous day.
Israeli pharmaceutical company Kamada raised $51.6 million in its initial public offering on Nasdaq last Friday, offering 5.6 million shares at $9.25 per share. That was16.6% below its Thursday closing price on the Tel Aviv Stock Exchange.
Like us on Facebook and get articles directly in your news feed